Home > Items where Subject is "B Substances > Sedatives, hypnotics or tranquillisers (CNS depressants) > Xylazine, detomidine, medetomidine"

up arrow imageUp a level
Export as
Group by: Item Type | No Grouping
Number of items at this level: 15.

Article

Cano, Manuel and Daniulaityte, Raminta and Marsiglia, Flavio (2024) Xylazine in overdose deaths and forensic drug reports in US States, 2019-2022. JAMA Network Open , 7 .

Sue, Kimberly L and Hawk, Kathryn (2024) Editorial. Clinical considerations for the management of xylazine overdoses and xylazine-related wounds. Addiction , 119 , (4) , pp. 606-608.

Nahar, Limon K and Andrews, Rebecca and Paterson, Sue (2023) Rapid response: Evolving use of recreational drugs in UK – Nitazenes and Xylazine. BMJ , 383 , p. 2280.

Zagorski, Claire M and Hosey, Rebecca A and Moraff, Christopher and Ferguson, Aaron and Figgatt, Mary and Aronowitz, Shoshana and Stahl, Natalie E and Hill, Lucas G and McElligott, Zoe and Dasgupta, Nabarun (2023) Reducing the harms of xylazine: clinical approaches, research deficits, and public health context. Harm Reduction Journal , 20 .

Rock, Kirsten L and Lawson, Alexander J and Duffy, Joanne and Mellor, Alice and Treble, Ric and Copeland, Caroline S (2023) The first drug-related death associated with xylazine use in the UK and Europe. Journal of Forensic and Legal Medicine , 97 .

Report

Advisory Council on the Misuse of Drugs. (2024) A review of the evidence on the use and harms of xylazine, medetomidine and detomidine. London: Advisory Council on the Misuse of Drugs.

Krotulski, Alex J and Manini, Alex F and Schwarz, Evan and Walton, Sara E and Fogarty, Melissa F and Logan, Barry K (2023) Medetomidine – NPS Discovery new drug monograph. United States: Center for Forensic Science Research & Education.

WEDINOS. (2023) PHILTRE annual report April 2022 - March 2023. Cardiff: WEDINOS.

International Narcotics Control Board. (2023) Report of the International Narcotics Control Board for 2022. Vienna: United Nations.

Harm Reduction International. (2022) The global state of harm reduction 2022. London: Harm Reduction International.

Centre on Drug Policy Evaluation. (2022) What’s contaminating Toronto’s drug supply? insights from samples checked by Toronto’s drug checking service January 1 - December 31, 2021. Toronto: Centre on Drug Policy Evaluation.

Krotulski, Alex J and Shinefeld, Jennifer and DeBord, Joshua and Logan, Barry K (2022) Fentanyl purity, potency, & synthesis: real-time testing of opioid drug products in the United States. USA: Center for Forensic Science Research and Education.

Canadian Centre on Substance Use and Addiction. (2022) CCENDU drug alert: Xylazine. Ottawa: Canadian Centre on Substance Use and Addiction.

Webpage

European Monitoring Centre for Drugs and Drug Addiction. (2023) Most recent data from the European Syringe Collection and Analysis Project Enterprise (ESCAPE): data explorer, analysis and key findings. URL: https://www.emcdda.europa.eu/publications/data-fac...

FactSheet

Addiction Technology Transfer Center Network. (2023) Understanding Xylazine: an emerging concern. Addiction Technology Transfer Center Network.

This list was generated on Thu Apr 11 04:30:33 2024 IST.